C96.22
BillableMast cell sarcoma
HCC Category Mapping
V28HCC 21 — Breast, Prostate, Colorectal and Other Cancers and Tumors
0.545V24HCC 10 — Lymphoma and Other Cancers
0.675ESRDHCC 10 — Lymphoma and Other Cancers
0.000RxHCCHCC 21 — Hodgkin Lymphoma and Other Cancers
0.000What This Code Means
A solid tumor composed of malignant mast cells that typically forms a localized mass.
Coding Tips
- •Mast cell sarcoma is a distinct entity from systemic mastocytosis; confirm the diagnosis is sarcoma not systemic disease
- •Document the primary site of the sarcoma if possible for complete coding
Clinical Significance
Mast cell sarcoma is an extremely rare malignant solid tumor composed of atypical mast cells that typically presents as a localized destructive mass. Unlike systemic mastocytosis, it begins as a localized tumor but may progress to systemic mast cell disease, carrying a very poor prognosis with limited effective treatment options.
Documentation Requirements
- ✓Documentation must include biopsy-confirmed malignant mast cell tumor with destructive local growth pattern, immunohistochemistry demonstrating mast cell markers (tryptase, CD117), and staging workup to assess for systemic spread.
- ✓The primary site, tumor size, and any evidence of progression to systemic disease should be documented.
Commonly Confused Codes
C96.21 (aggressive systemic mastocytosis) is a systemic disease rather than a localized tumor. D47.09 (other mastocytoma) is for benign mast cell tumors. C94.3(mast cell leukemia) involves bone marrow and blood rather than a solid mass. C96.20 (unspecified malignant mast cell neoplasm) lacks specificity.